title: Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
authors.affiliation: Department of Urolegy, Kitasato University, School of Medicine, Sagamihara, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kumano
authors.forename: A
authors.initials: A
authors.lastname: Irie
authors.forename: S
authors.initials: S
authors.lastname: Mashimo
authors.forename: T
authors.initials: T
authors.lastname: Endo
authors.forename: K
authors.initials: K
authors.lastname: Koshiba
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003404:Creatinine / Q000097:blood; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids; D003404:Creatinine; D008775:Methylprednisolone